Cardinal Health has been notified by Hospira that they are currently experiencing a supply disruption on the large volume
solution products listed below. During a routine shutdown and inspection of Hospira’s manufacturing facility in December,
2012, a quality issue was detected. The quality issue has been addressed and manufacturing processes have resumed.
Please note that the quality issue did not impact any pharmaceutical products manufactured within the facility.
No comments:
Post a Comment